Request an Appointment
Share Share to Facebook Share to Twitter Share via Email Print This Page More...

Clinical Trials by Condition

 

Please find clinical trials at HSS listed by the following conditions:

Non-orthopedic and non-rheumatologic clinical trials are conducted at Weill Cornell Medical College, an affiliate of Hospital for Special Surgery. Learn more

APS (Antiphospholipid Syndrome)

IRB# Clinical Trial Principal Investigator
10130 Effect of Hydroxychloroquine on the Annexin A5 Resistance Assay in Antiphospholipid Antibody-Positive Patients with and without Systemic Lupus Erythematosus Doruk Erkan, MD
28005 Effects of Fluvastatin on Proinflammatory and Prothrombotic markers in Antiphospholipid Syndrome Doruk Erkan, MD
28023 Cognitive Dysfunction, Diffusion Tensor Imaging and Functional Magnetic Resonance Imaging (MRI) in Antiphospholipid Antibody (aPL)-negative Systemic Lupus Erythematosus (SLE) versus aPL-positive non-SLE Patients Doruk Erkan, MD
27022 RITAPS: A Pilot Study Of Rituximab For The Anticoagulation-Resistant Manifestations Of Antiphospholipid Syndrome (APS) Doruk Erkan, MD
22122 PROMISSE: Predictors of Pregnancy Outcome: Biomarkers in Anti-Phospholipid Antibody Syndrome (APS) and Systemic Lupus Erythematosus (SLE) Jane E. Salmon, MD
95004 Autoimmune Disease Registry and Repository Jane E. Salmon, MD


Arthritis

IRB# Clinical Trial Principal Investigator
26043 A Study of Hyaluronan (Synvisc) for the Treatment of Osteoarthritis in the Thumb: Randomized Control Trial Lisa A. Mandl, MD, MPH
25022 Quantitative Assessment of the Synovial Vascularity in Early Inflammatory Arthritis Lisa A. Mandl, MD, MPH
11096 Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry38880 Thomas J.A. Lehman, MD
23034 Open Label Trial for Treating Carpometacarpal Osteoarthritis: PILOT STUDY - Sub-study on Normal Controls Lisa A. Mandl, MD, MPH
23108 Evaluation of Intra-articular Injuries as Predictors of Function and Arthritis Robert G. Marx, MD
24067 Database of the Gosden Robinson Early Arthritis Center (EAC): Analysis of Types of Patients Recruited to an Urban EAC Lisa C. Vasanth, MD
22007 Hyalgan Treatment of Osteoarthritis in Post-Operative Knee Arthroplasty Patients Geoffrey Westrich, MD
26035 Arthroscopic Partial Meniscectomy in Osteoarthritis: A Randomized Control Trial Lisa A. Mandl, MD, MPH


Arthroplasty

IRB# Clinical Trial Principal Investigator
26117 HSS Shoulder Joint Replacement Registry Robert Marx MD, MSc
27027 Vitamin D Status Among Trauma Patients; Acute Fractures/Non-unions vs. Primary Joint Arthroplasty (control population) Joseph M. Lane, MD
26073 Evaluation of migration of a cementless, flat, tapered femoral component using RSA Edwin P. Su, MD
22007 Hyalgan Treatment of Osteoarthritis in Post-Operative Knee Arthroplasty Patients Geoffrey Westrich, MD
28041 The Effect of Ischemic Preconditioning on Systemic Inflammatory Markers after Total Knee Arthroplasty Stavros G. Memtsoudis, MD
26115 Minimally Invasive Surgical Approach versus Standard Total Knee Arthroplasty: A Prospective Randomized Double Blinded Study Comparing Postoperative Strength Bryan J. Nestor. MD
26079 Deep Vein Thrombosis (DVT) Prevention in Total Hip Replacement: Continuous Enhanced Circulation Therapy (CECT) Versus Low Molecular Weight Heparin (LMWH) Douglas E. Padgett, MD
21072 The Genetic Factor: Identifying Patients at High Risk for Developing Pulmonary Embolism (PE) After Orthopedic Surgery (Upper Extremity, Spine, THR, TKR) Using A Molecular Screening Test Geoffrey H. Westrich, MD


Foot and Ankle Conditions


   Ankle Conditions

IRB# Clinical Trial Principal Investigator
11066 Randomized Controlled Trial of Platelet-Rich Plasma Versus Whole Blood in the Treatment of Chronic Mid-Portion Achilles Tendinosis John G. Kennedy, MD
11040 A Prospective, Randomized, Controlled, Multi-Center, Pivotal Human Clinical Trial to Evaluate the Safety and Effectiveness of Augment™ Injectable Bone Graft Compared to Autologous Bone Graft as a Bone Regeneration Device in Hindfoot Fusions Andrew J. Elliott, MD
28086 Does Pregabalin Reduce Pain after Ankle Surgery? Jacques T YaDeau, MD, PhD
10105 Duration of Analgesia after Popliteal Fossa Nerve Blockade: Effects of Dexamethasone and Buprenorphine Jacques T, Ya Deau, MD, PhD



   Foot Conditions

IRB# Clinical Trial Principal Investigator
11066 Randomized Controlled Trial of Platelet-Rich Plasma Versus Whole Blood in the Treatment of Chronic Mid-Portion Achilles Tendinosis John G. Kennedy, MD
11040 A Prospective, Randomized, Controlled, Multi-Center, Pivotal Human Clinical Trial to Evaluate the Safety and Effectiveness of Augment™ Injectable Bone Graft Compared to Autologous Bone Graft as a Bone Regeneration Device in Hindfoot Fusions Andrew J. Elliott, MD
10105 Duration of Analgesia after Popliteal Fossa Nerve Blockade: Effects of Dexamethasone and Buprenorphine Jacques T, Ya Deau, MD, PhD
28019 Early Mobilization following Adult Acquired Flatfoot Deformity Reconstruction Jonathan T. Deland, M.D.
10002 Analgesia after Total Knee Arthroplasty: Peri-Articular Injection vs. Epidural + Femoral Nerve Blockade Jacques T. YaDeau, MD, PhD
10023 Pharmacodynamics of Ultrasound Guided Popliteal Catheter Infusion after Foot and Ankle Surgery Daniel B. Maalouf, MD, MPH
10015 Understanding the Effects of the “Ankle Sprain Reducing Shoe” on Ankle Joint Kinetics, Kinematics, Electromyography, and Neuromuscular Balance Control: A Pilot Study Allison M. Brown, PT, MA
28021 In Vivo Radiographic Validation of Novel EMED Plantar Pressure Masking Algorithm Jonathan T. Deland, MD
26071 Development of a Geometric Foot Model: A Tool for Clinical Decision Making Howard J. Hillstrom, PhD


Knee Conditions

IRB# Clinical Trial Principal Investigator
11174 The Effect of Postoperative Blood Transfusions on Muscle Tissue Oxygenation after Hip and Knee Arthroplasty. Stavros G. Memtsoudis, MD, PhD
28008 Lower Extremity Realignment Therapy for the Treatment of Medial Knee Osteoarthritis- A Pilot Study Howard J. Hillstrom, PhD
11079 Catheter Lateralization by Electrical Stimulation during Epidural Anesthesia Nigel E. Sharrock, MD
27127 Prospective Study of the effects of Femoral Nerve Block on Quadriceps Strength Post ACL Allograft Reconstruction Thomas L. Wickiewicz, MD
22129 Bone Tunnel Widening Following ACL (Anterior Cruciate Ligament) Reconstruction Scott Rodeo, MD
26035 Arthroscopic Partial Meniscectomy in Osteoarthritis: A Randomized Control Trial Lisa A. Mandl, MD, MPH
11043 Effects of Pregabalin on Pain after Total Knee Arthroplasty: A Dose-Response Study Jacques T. YaDeau, MD, PhD
28041 The Effect of Ischemic Preconditioning on Systemic Inflammatory Markers after Total Knee Arthroplasty Stavros G. Memtsoudis, MD
10146 Saphenous (Adductor Canal) Nerve Block vs. Femoral Nerve Block for Total Knee Arthroplasty: A Novel Approach for Postoperative Analgesia David H. Kim, MD
10122 Revision Anterior Cruciate Ligament Reconstruction in Adolescents Frank A. Cordasco, MD
26115 Minimally Invasive Surgical Approach versus Standard Total Knee Arthroplasty: A Prospective Randomized Double Blinded Study Comparing Postoperative Strength Bryan J. Nestor. MD
27142 A Randomized Comparison of NeoCart® to Microfracture for the Repair of Articular Cartilage Injuries in the Knee Riley J. Williams III, MD


Lupus

IRB# Clinical Trial Principal Investigator
11113 A Phase 2B, Dose Ranging Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults with SLE Kyriakos A. Kirou, MD, DSc, FACP
10117 A Phase 1 Double Blind, Randomized, Single Ascending Dose Study of the Safety and Tolerability of MEDI 570 in SLE Kyriakos A. Kirou, MD
10130 Effect of Hydroxychloroquine on the Annexin A5 Resistance Assay in Antiphospholipid Antibody-Positive Patients with and without Systemic Lupus Erythematosus Doruk Erkan, MD
11141 A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Subcutaneous LY2127399 in Patients with Systemic Lupus Erythematosus (SLE) (ILLUMINATE-2) Doruk Erkan, M.D.
22122 PROMISSE: Predictors of Pregnancy Outcome: Biomarkers in Anti-Phospholipid Antibody Syndrome (APS) and Systemic Lupus Erythematosus (SLE) Jane E. Salmon, MD
29099 A Phase II Randomized Double- Blind, Placebo- Controlled Study to Evaluate the Efficacy and Safety of Rontalizumab (rhuMAb IFNalpha) In Patients with Moderately to Severely Active SLE. Kyriakos A. Kirou, MD
93029 Fc Receptor Function in Normals and Systemic Lupus Erythematosus (SLE) Jane E. Salmon, MD
95004 Autoimmune Disease Registry and Repository Jane E. Salmon, MD

Please visit the Mary Kirkland Center for Lupus Research and the Lupus Clinical Trials Consortium for more information on lupus research.



Neurological Disorders


   ALS (Amyotrophic Lateral Sclerosis)

IRB# Clinical Trial Principal Investigator
29093 Clinical Trial of Ceftriaxone in Subjects with Amyotrophic Lateral Sclerosis Dale J. Lange, M.D.
29094 Safety and Tolerability of the Ketogenic Diet in ALS Dale J. Lange, MD
10062 Safety and Efficacy of SOD1 Inhibition by Pyrimethadine in Sporadic ALS Dale J. Lange, MD
29084 Safety and Efficacy of SOD1 Inhibition by Pyrimethadine in Familial ALS Dale J. Lange, MD


Shoulder Conditions

IRB# Clinical Trial Principal Investigator
27122 Supraclavicular vs Interscalene Brachial Plexus Block for Shoulder Surgery Christopher A DiMeo, MD
27020 Intraarticular Corticosteroid Injection for Idiopathic Adhesive Capsulitis of the Shoulder Jennifer L. Solomon, MD
27071 Adhesive Capsulitis: A Quantitative Analysis of Myofibroblast Proliferation Jo A Hannafin, MD
27050 The Effect of McConnell Shoulder Taping on EMG Activity and Torque Production of the Shoulder Muscles in Subjects With Anterior Shoulder Instability Sherry I. Backus PT, DPT, MA
11035 Rotator Cuff Repair: A Prospective Randomized Trial Evaluating Two Commonly Performed Techniques Frank A. Cordasco, M.D.


Spine Conditions

IRB# Clinical Trial Principal Investigator
26118 Genetic Mapping Studies of Adolescent Idiopathic Scoliosis Cathleen L. Raggio, MD
27016 Osteogenic Differentiation of Human Mesenchymal Stem Cells Wei Zhu, Ph.D.
26033 Unipedicular vs. Bipedicular Kyphoplasty for the Treatment of Osteoporotic Vertebral Fractures Joseph M. Lane, MD


Skeletal Dysplasias

IRB# Clinical Trial Principal Investigator
23125 The Kathryn O. and Alan C. Greenberg Center for Skeletal Dysplasias Clinical Research Registry Cathleen Raggio, MD
25039 A Randomized Double Blind Placebo Controlled Multi-Center Parallel Group Study of One Year Duration Followed by Two Years of open-label Treatment to Determine the Safety and Efficacy of Orally Administered 2.5 mg or 5.0 mg Daily Risedronate Cathleen L. Raggio, MD


Scleroderma

IRB# Clinical Trial Principal Investigator
10041 Nilotinib in the Treatment of Systemic Sclerosis Robert F. Spiera, MD
10115 The Natural History and Outcome of Scleroderma Patients at High Risk or with Early Pulmonary Hypertension Jessica K. Gordon, MD
27049 Gleevec in the Treatment of Systemic Sclerosis Robert F. Spiera, MD
26069 Scleroderma Registry Robert Spiera, MD
10168 DISTOL 1: Digital Ischemic Lesions in Scleroderma Treated with Oral Treprostinil Diethanolamine: a Randomized, Double-blind, Placebo-controlled, Multicenter Study Robert F. Spiera, MD


Osteoporosis

IRB# Clinical Trial Principal Investigator
27041 Fragile Bone Registry Joseph M. Lane, MD
26033 Unipedicular vs. Bipedicular Kyphoplasty for the Treatment of Osteoporotic Vertebral Fractures Joseph M. Lane, MD
23017 CORRONA Data Collection Program Allan Gibofsky, MD
10001 A Randomized, Controlled, Double-Blind Study of the Early Effects of Teriparatide versus Placebo on the Proximal Femur Mathias P. G. Bostrom, M.D.


 
Share
Share to Facebook Share to Twitter Share via Email Print This Page More...